Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Levobupivacaína Normon 5 mg/ml solución inyectable y para perfusión EFG, Inibsacain 5 mg/ml + 0,005 mg/ml solución inyectable en cartucho
The George Institute
Hip fracture
1 trial -
Livmarli 9.5 mg/mL oral solution
Lacuna Pharma Pty Ltd
Progressive Familial Intrahepatic Cholestasis, Alagille syndrome
1 trial -
MUCODRILL 600 mg SANS SUCRE, comprimé effervescent édulcoré au sucralose, FOLINORAL 25 mg, gélule, VITAMINE B12 GERDA 250 microgrammes, comprimé sécable, Omacor 1000 mg capsules molles
Pari Pharma GmbH
Ultra High Risk of psychosis and first episode psychosis
1 trial -
Minoxidil lotion 1%
Hospital Authority, Hong Kong
Eyebrow Hypotrichosis
1 trial -
Minoxidil lotion 2%
Hospital Authority, Hong Kong
Hypotrichosis of Eyebrows
1 trial -
Mobile Surgical Vehicle Echocardiography-guided ASD closure Group
Xiyuan Hospital of China Academy of Chinese Medical Sciences
ASD - Atrial Septal Defect
1 trial -
Pimavanserin
Acadia Pharmaceuticals B.V.
Parkinson Disease Psychosis
1 trial -
Placebo of rosuvastatin 10mg (tablet) as produced by Apotheek A15, Rosuvastatin tablet 10mg Apotheek A15
Disc Medicine
Statin-intolerance, High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)
1 trial -
Praluent
Regeneron UK Limited
Heterozygous Familial Hypercholesterolemia
1 trial -
Praluent (Alirocumab)
Regeneron UK Limited
Hypercholesterolemia
1 trial -
Provase
Chongqing Precision Biotech Co., Ltd
Pruritus
1 trial -
ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, Placebo to KJX839 (Inclisiran sodium) 0 mg/1.5 mL solution for injection in pre-filled syringe, INCLISIRAN
Novartis Pharmaceuticals
Hypercholesterolemia
1 trial -
Recombinant human growth hormone
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Achondroplasia
1 trial -
Recombinant subunit B/bacterial cholera vaccine (enteric-coated capsules)
United Therapeutics Europe Ltd
Diarrhea
1 trial -
Rescue Intravitreal Aflibercept Injection
Regeneron UK Limited
Neovascular Polypoidal Choroidal Vasculopathy
1 trial -
Rosuvastatin and Ezetimibe morning or evening administration
COLLEGIUM PHARMACEUTICAL, INC
Hypercholesterolemia
1 trial -
Salkera Emollient Foam
Chongqing Precision Biotech Co., Ltd
Keratosis Pilaris
1 trial -
Same form and composition of the drug, except for the active ingredient., BRONCHO VAXOM Adulti 7 mg capsule rigide
Fondazione Telethon ETS
Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.
1 trial -
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
Sanofi Pasteur
Cholera
1 trial -
Succinylcholine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
the Effect of Succinylcholine on Barrier Pressure
1 trial -
TACHOSIL GROUP
Takeda
Lymphocele
1 trial -
Test preparation:Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Asthma
1 trial -
Test preparation:Methylcholine chloroacetate for inhalation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy People
1 trial -
The placebo MDI is formulated as a suspension of spray-dried porous particles (consisting of 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC] and calcium chloride) in a hydrofluoroalkane propellant (HFA-134a). The placebo MDI uses the same excipients as active product but with absence of the active pharmaceutical ingredient (API)., Trixeo Aerosphere 5 micrograms/7.2 micrograms/160 micrograms pressurised inhalation, suspension
AstraZeneca AB
Chronic Obstructive Pulmonary Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources